Thorac Cardiovasc Surg 2012; 60(02): 135-139
DOI: 10.1055/s-0030-1270990
Original Thoracic
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Approach to Patients with Chylothorax Complicating Pulmonary Resection

H. Akin
1   Department of Thoracic Surgery, Yedikule Teaching Hospital for Chest Diseases and Chest Surgery, Istanbul, Turkey
,
A. Olcmen
1   Department of Thoracic Surgery, Yedikule Teaching Hospital for Chest Diseases and Chest Surgery, Istanbul, Turkey
,
O. Isgorucu
1   Department of Thoracic Surgery, Yedikule Teaching Hospital for Chest Diseases and Chest Surgery, Istanbul, Turkey
,
I. Denizkiran
1   Department of Thoracic Surgery, Yedikule Teaching Hospital for Chest Diseases and Chest Surgery, Istanbul, Turkey
,
I. Dincer
1   Department of Thoracic Surgery, Yedikule Teaching Hospital for Chest Diseases and Chest Surgery, Istanbul, Turkey
› Author Affiliations
Further Information

Publication History

07 November 2010
09 December 2010

03 January 2011

Publication Date:
09 May 2011 (online)

Abstract

Mediastinal lymph node dissection, an important part of surgery for non-small cell lung cancer, is associated with a risk of chylothorax. Although mortality has significantly decreased in recent years, it still worries thoracic surgeons. In this report we reviewed our experience on chylothorax with 26 cases and assessed the outcomes after conservative and surgical approaches. Between January 2000 and June 2010, twenty-six patients developed chylothorax after pulmonary resection performed for non-small cell lung cancer. Initially, all cases were treated conservatively with cessation of oral intake and the application of talc poudrage. If the conservative method failed, a surgical approach was used, which consisted either of suturing the leak or of mass ligation. The mean age of patients was 56 ± 9.05 years, and 3 were female. Chylothorax was more common on the right side, in lobectomy cases, in cases with adenocarcinoma, and in patients with advanced stage lung cancer, but the difference did not reach statistical significance. Conservative treatment was successful in 19 of 26 (73 %) patients, four of whom had undergone pneumonectomy. Seven out of 26 cases (27%) required thoracotomy to control the chylous leak. Though thoracotomy was required mostly for the right side (6 right vs. 1 left, p = 0.15), and in patients who had had pneumonectomy as their first operation (4 patients vs. 3, p = 0.18), this did not reach statistical significance. No patient died as a result of surgical intervention. In conclusion, chylothorax is not rare after pulmonary resection performed for lung cancer. But it is not as dangerous as it used to be. Talc pleurodesis has increased the success of conservative management and minimized the need for surgical intervention. In cases of high output leak the surgeon should not hesitate to perform surgery. VATS can be performed instead of open surgery in suitable cases.

 
  • References

  • 1 Kutlu CA, Sayar A, Olgac G, Akin H , et al. Chylothorax: a complication following lung resection in patients with NSCLC: chylothorax following lung resection. Thorac Cardiovasc Surg 2003; 51: 342-345
  • 2 Mountain CF. Revisions in the international system for staging. Lung Cancer Chest 1997; 111: 1710A-1717A
  • 3 Nair SK, Petko M, Hayward MP. Aetiology and management of chylothorax in adults. Eur J Cardiothorac Surgery 2007; 32: 362-369
  • 4 Fahimi H, Casselman FP, Mariani MA , et al. Current management of postoperative chylothorax. Ann Thorac Surg 2001; 71: 448-451
  • 5 Kanjanauthai S, Kanluen T, Bergman M. Tension chylothorax: a rare life threatening entity after pneumonectomy. Heart Lung Circ 2009; 18: 52-61
  • 6 Paul S, Altorki NK, Port JL, Stiles BM, Lee PC. Surgical management of chylothorax. Thorac Cardiov Surg 2009; 57: 226-228
  • 7 Le Pimpec-Barthes F, D'Attellis N, Dujon A , et al. Chylothorax complicating pulmonary resection. Ann Thorac Surg 2002; 73: 1714-1719
  • 8 Johnstone DW. Anatomy of the thoracic duct and chylothorax. In: Shields TW, LoCicero J, Reed CE, Feins RH, eds. General thoracic surgery. 7th. ed. New York: Lippincott Williams and Wilkins;; 2007: 827-833
  • 9 Itkin M, Kucharczukb JC, Kwak A, Trerotola SO, Kaiser LR. Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J Thorac Cardiovasc Surg 2010; 139: 584-590
  • 10 Boffa DJ, Mark J, Sands MJ , et al. A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery. Eur J Cardiothorac Surg 2008; 33: 435-439
  • 11 Gómez-Caro AA, Moradiellos Diez FJ, Marrón CF, Larrú Cabrero EJ, Martín de Nicolás JL. Conservative management of postsurgical chylothorax with octreotide. Asian Cardiovasc Thorac Ann 2005; 13: 222-224
  • 12 Çobanoğlu U, SayŁr F, İliklerden DM, BartŁn K. Şilotoraks tedavisinde cerrahiye alternatif bir metot: somatostatin uygulanmasŁ. Van TŁp Dergisi 2010; 17 (2) 54-57
  • 13 KarapŁnar K, Ulular Ü, Şahinalp Ş, Ersoy Ü, ÜzŁşŁk K, Yücel E. Şilotoraks tedavisinde somatostatin etkisi: olgu sunumu. Bidder TŁp Bilimleri Dergisi 2010; 2: 28-30
  • 14 Orringer MB, Bluett M, Deeb GM. Aggressive treatment of chylothorax complicating transhiatal esophagectomy without thoracotomy. Surgery 1988; 104: 720-726
  • 15 Christodoulou M, Ris H, Pezzetta E. Video-assisted right supradiaphragmatic thoracic duct ligation for non-traumatic recurrent chylothorax. Eur J Cardiothorac Surg 2006; 29: 810-814
  • 16 Vassalloa BC, Cavadas D, Beveraggia E, Sivori E. Treatment of postoperative chylothorax through laparoscopic thoracic duct ligation. Eur J Cardiothorac Surg 2002; 21: 556-557